1. Home
  2. LGVN vs WAFU Comparison

LGVN vs WAFU Comparison

Compare LGVN & WAFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Longeveron Inc.

LGVN

Longeveron Inc.

N/A

Current Price

$6.96

Market Cap

21.4M

Sector

Health Care

ML Signal

N/A

WAFU

Wah Fu Education Group Limited

N/A

Current Price

$1.43

Market Cap

5.8M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
LGVN
WAFU
Founded
2014
1999
Country
United States
China
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
21.4M
5.8M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
LGVN
WAFU
Price
$6.96
$1.43
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
302.6K
31.1K
Earning Date
05-08-2026
07-31-2026
Dividend Yield
N/A
N/A
EPS Growth
50.76
N/A
EPS
N/A
N/A
Revenue
$709,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$1.22
52 Week High
$7.36
$3.06

Technical Indicators

Market Signals
Indicator
LGVN
WAFU
Relative Strength Index (RSI) 79.06 47.86
Support Level $0.61 $1.32
Resistance Level $7.30 $1.70
Average True Range (ATR) 0.47 0.07
MACD 0.08 0.01
Stochastic Oscillator 89.31 36.09

Price Performance

Historical Comparison
LGVN
WAFU

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

About WAFU Wah Fu Education Group Limited

Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions, and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.

Share on Social Networks: